Structure (Ezetimibe 1)
Ezetimibe Tablet
Product Images NDC 51660-200
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ezetimibe (NDC 51660-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ohm Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\ezetimibe\20191217_5b3842f6-c80a-47b8-8a82-b69e465b05f7\ezetimibe-2.jpg (Ezetimibe 2)
This is a medication label including the name of the manufacturer, Ohm Laboratories Inc., as well as the location of the company in New Brunswick, NJ. It also states that the medication was manufactured and distributed by Sun Pharmaceuticals Industries, Inc. in Cranbury, NJ. There is no medication name or indication available.*
S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\ezetimibe\20191217_5b3842f6-c80a-47b8-8a82-b69e465b05f7\ezetimibe-3.jpg (Ezetimibe 3)
S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\ezetimibe\20191217_5b3842f6-c80a-47b8-8a82-b69e465b05f7\ezetimibe-4.jpg (Ezetimibe 4)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
